Carbon and 2D materials are showing very promising results in the biomedical field. They are explored for many biomedical applications, particularly for cancer treatment, due to their unique physicochemical characteristics. In this presentation, I will describe the characteristics of biodegradability and illustrate how an appropriate chemical modification of these materials renders them more biocompatible and can accelerate their biodegradability. I will focus in particular on our recent results aiming to design a smart multifunctional graphene platform able to both selectively deliver a drug into cells in a targeted manner and displaying an enhanced propensity for enzymatic degradation.

---

Bio

Alberto Bianco received his PhD in 1995 from the University of Padova (Italy). As a visiting scientist, he worked at the University of Lausanne (Switzerland), the University of Tübingen (Germany) (as an Alexander von Humboldt fellow) and the University of Padova. He is currently Research Director at the CNRS in Strasbourg. His research interests focus on the design of multifunctional carbon-based nanomaterials (carbon nanotubes, graphene and adamantane) for therapeutic, diagnostic and imaging applications. He has been invited to Japan as JSPS fellow in 2012 (Tohoku University, Sendai) and 2105 (AIST, Tsukuba), and as visiting Professor in 2019 (Kyoto University). He is in the Board of the French Society for the Studies on Carbon (SFEC) and of the International Research Network on Graphene and Nanotubes (GDRI-GNT). In 2017 he has been elected Fellow of the European Academy of Science (EURASC). In 2019 he has obtained the CNRS Silver Medal. He is co-author of over 260 papers. He is in the Advisory Board of Nanomedicine, Nanotechnology Reviews and the Journal of Peptide Science. Since 2011 he is Editor of the journal Carbon..